Abstract:The aim of the present study was to investigate the effect of dihydroartemisinin (DHA) on a multiple myeloma cell line. An MTT assay, flow cytometry and reverse transcription-polymerase chain reaction (RT-PCR) were used for the analysis of cell viability, cell cycle distribution and c-Jun N-terminal kinase (JNK) expression, respectively. Treatment of U266 cells using DHA caused a significant (P<0.05) decrease in cell viability compared with the control cells. An increase in the concentration of DHA from 1 to 100 µmol/l reduced cell viability from 87 to 35% compared with 100% in the control cultures at 48 h. A significant (P<0.05) increase was observed in the sub-G0/G1 phase population of the U266 cells with an increase in DHA concentration from 1 to 100 µmol/l. Treatment with 1, 3, 10, 30 and 100 µmol/l concentrations of DHA increased the sub-G0/G1 phase cell population to 3.13, 8.25, 24.91, 31.47 and 38.54%, respectively. RT-PCR analysis of DHA-treated or -untreated U266 cells after 48 h demonstrated a significant (P<0.01) increase in caspase-3 expression. Treatment of the cells for 48 h with DHA led to a significant increase in c-Jun expression. DHA treatment at 1, 3, 10, 30 and 100 µmol/l concentrations caused an increase in the level of c-Jun by 0.174±0.001, 0.254±0.002, 0.387±0.001, 0.502±0.003 and 0.679±0.005, respectively, compared with 0.982±0.001 in the control cells. The addition of SP600125 to the cells incubated with DHA resulted in a significant decrease in the caspase-3 and c-Jun expression levels compared with those cells incubated with DHA alone. These findings confirm that treatment with DHA increased caspase-3 and c-Jun expression in the U266 cells through activation of the JNK signaling pathway. Thus, DHA inhibited proliferation of multiple myeloma cells by interfering with the JNK signaling pathway.

The Jnk Inhibitor Sp600125 Enhances Dihydroartemisinin-Induced Apoptosis by Accelerating Bax Translocation into Mitochondria in Human Lung Adenocarcinoma Cells

Bax Translocation into Mitochondria During Dihydroartemisinin(Dha)-Induced Apoptosis in Human Lung Adenocarcinoma Cells

Single-cell Analysis of Dihydroartemisinin-Induced Apoptosis Through Reactive Oxygen Species-Mediated Caspase-8 Activation and Mitochondrial Pathway in ASTC-a-1 Cells Using Fluorescence Imaging Techniques.

Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation.

Dihydroartemisinin (DHA) Induces Caspase-3-dependent Apoptosis in Human Lung Adenocarcinoma ASTC-a-1 Cells

Ecliptasaponin A induces apoptosis through the activation of ASK1/JNK pathway and autophagy in human lung cancer cells.

Dihydroartemisinin Induces Apoptosis Preferentially Via a Bim-mediated Intrinsic Pathway in Hepatocarcinoma Cells

Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells.

Artemisinin Induces Caspase-8/9-mediated and Bax/Bak-independent Apoptosis in Human Lung Adenocarcinoma (Astc-a-1) Cells

Novel dihydroartemisinin derivative DHA-37 induces autophagic cell death through upregulation of HMGB1 in A549 cells

Dihydroartemisinin Treatment of Multiple Myeloma Cells Causes Activation of C-Jun Leading to Cell Apoptosis.

Dihydroartemisinin Increases Apoptosis of Colon Cancer Cells Through Targeting Janus Kinase 2/signal Transducer and Activator of Transcription 3 Signaling.

Ionizing Radiation Potentiates Dihydroartemisinin-Induced Apoptosis Of A549 Cells Via A Caspase-8-Dependent Pathway

Involvement of the Mitochondrial Pathway and Bim/Bcl-2 Balance in Dihydroartemisinin-Induced Apoptosis in Human Breast Cancer in Vitro

Synergistic Induction of Apoptosis in A549 Cells by Dihydroartemisinin and Gemcitabine

Artemisinin induces caspase-8/9-mediated and Bax/Bak-independent apoptosis in human lung adenocarcinoma (ASTC-a-1) cells.

Dihydroartemisinin Inhibits Glucose Uptake and Cooperates with Glycolysis Inhibitor to Induce Apoptosis in Non-Small Cell Lung Carcinoma Cells

Potent Proapoptotic Actions of Dihydroartemisinin in Gemcitabine-Resistant A549 Cells.

Dihydroartemisinin-induced Apoptosis in Human Acute Monocytic Leukemia Cells.

Induction of Apoptosis and Inhibition of Cell Migration and Tube-Like Formation by Dihydroartemisinin in Murine Lymphatic Endothelial Cells

Interruption of the MEK/ERK Signaling Cascade Promotes Dihydroartemisinin-Induced Apoptosis in Vitro and in Vivo